Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 9167107)

Published in Diabetes Care on June 01, 1997

Authors

M R Christie1, U Roll, M A Payton, E C Hatfield, A G Ziegler

Author Affiliations

1: Department of Medicine, King's College School of Medicine, London, U.K. m.christie@kcl.ac.uk

Articles by these authors

The osmotic integrity of the yeast cell requires a functional PKC1 gene product. Mol Cell Biol (1992) 2.78

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia (2010) 2.65

No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM. Diabetes Care (1995) 2.14

Pattern of month of birth in diabetic and non-diabetic adults. Isr Med Assoc J (2002) 2.03

Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia (2009) 2.00

Characterization of the yeast (1-->6)-beta-glucan biosynthetic components, Kre6p and Skn1p, and genetic interactions between the PKC1 pathway and extracellular matrix assembly. J Cell Biol (1994) 1.94

Antibodies to bovine serum albumin (BSA) in type 1 diabetes and other autoimmune disorders. Exp Clin Endocrinol Diabetes (1997) 1.43

HIV-1 Rev expressed in recombinant Escherichia coli: purification, polymerization, and conformational properties. Biochemistry (1991) 1.38

Transmission ratio distortion at the INS-IGF2 VNTR. Nat Genet (1999) 1.34

Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. J Immunol (1999) 1.29

The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolution. Nat Struct Biol (1996) 1.27

Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care (1988) 1.27

Protein kinase C in yeast. Characteristics of the Saccharomyces cerevisiae PKC1 gene product. J Biol Chem (1994) 1.27

Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives. Diabetologia (2008) 1.25

Development of celiac disease-associated antibodies in offspring of parents with type I diabetes. Diabetologia (2000) 1.23

Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care (1992) 1.21

Breastfeeding habits in families with Type 1 diabetes. Diabet Med (2007) 1.20

Conversion of Glucose to 2-Keto-l-Gulonate, an Intermediate in l-Ascorbate Synthesis, by a Recombinant Strain of Erwinia citreus. Appl Environ Microbiol (1988) 1.20

Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J Immunol (1998) 1.19

No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care (2000) 1.15

Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest (1997) 1.14

The Candida albicans PKC1 gene encodes a protein kinase C homolog necessary for cellular integrity but not dimorphism. Yeast (1996) 1.12

Cellular immune response to diverse islet cell antigens in IDDM. Diabetes (1996) 1.11

Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care (2001) 1.11

Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes (1997) 1.10

Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia (1998) 1.10

No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun (2001) 1.09

Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes (1993) 1.09

Immunoglobulin G insulin autoantibodies in BABYDIAB offspring appear postnatally: sensitive early detection using a protein A/G-based radiobinding assay. J Clin Endocrinol Metab (1999) 1.08

PMI40, an intron-containing gene required for early steps in yeast mannosylation. Mol Cell Biol (1992) 1.08

Purification, cDNA cloning and heterologous expression of human phosphomannose isomerase. Eur J Biochem (1994) 1.07

Development of autoimmunity to transglutaminase C in children of patients with type 1 diabetes: relationship to islet autoantibodies and infant feeding. Diabetologia (2006) 1.07

BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with Type 1 diabetes by delaying exposure to gluten. Diabetologia (2004) 1.05

The Candida albicans PMM1 gene encoding phosphomannomutase complements a Saccharomyces cerevisiae sec 53-6 mutation. Curr Genet (1992) 1.04

Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives. Diabetologia (2006) 1.03

Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study. Diabetologia (1999) 1.03

Modelling the initial phase of an epidemic using incidence and infection network data: 2009 H1N1 pandemic in Israel as a case study. J R Soc Interface (2011) 1.02

Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes (2000) 1.01

Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases. Diabetologia (2012) 1.00

Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Hum Mol Genet (2000) 0.99

Yeast alpha-mating factor receptor-linked G-protein signal transduction suppresses Ras-dependent activity. FEBS Lett (1991) 0.98

GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes (1998) 0.98

Psychological impact of childhood islet autoantibody testing in families participating in the BABYDIAB study. Diabet Med (2004) 0.98

Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia (2013) 0.96

The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial. Allergy (2012) 0.96

Phosphomannose isomerase from Saccharomyces cerevisiae contains two inhibitory metal ion binding sites. Biochemistry (1993) 0.95

A Ca(2+)-independent protein kinase C from fission yeast. J Biol Chem (1993) 0.95

Changes of vitamin D3 serum concentrations at the onset of immune-mediated type 1 (insulin-dependent) diabetes mellitus. Diabetes Res (1991) 0.94

Industrial prospects for thermophiles and thermophilic enzymes. Biochem Soc Symp (1983) 0.94

Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J Clin Endocrinol Metab (2001) 0.92

Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial. Diabetologia (1998) 0.89

High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM. Diabetes (1997) 0.88

Early infant diet in children at high risk for type 1 diabetes. Horm Metab Res (2009) 0.88

Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes (1996) 0.88

PWP2, a member of the WD-repeat family of proteins, is an essential Saccharomyces cerevisiae gene involved in cell separation. Mol Gen Genet (1996) 0.87

Cloning and heterologous expression of the Candida albicans gene PMI 1 encoding phosphomannose isomerase. Yeast (1995) 0.85

Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest (1996) 0.85

Cross reactivity between IA-2 and phogrin/IA-2beta in binding of autoantibodies in IDDM. Diabetologia (1997) 0.84

Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. J Autoimmun (1996) 0.84

Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459. Allergy (2014) 0.84

Purification and characterization of fungal and mammalian phosphomannose isomerases. J Protein Chem (1994) 0.83

Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients. Diabetes (1994) 0.83

Hyphal tip extension in Aspergillus nidulans requires the manA gene, which encodes phosphomannose isomerase. Mol Cell Biol (1994) 0.83

L-pilin variants of Neisseria gonorrhoeae MS11. Mol Microbiol (1991) 0.83

Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens. Diabetes (2000) 0.83

In vivo and in vitro folding of a recombinant metalloenzyme, phosphomannose isomerase. Biochem J (1996) 0.82

Proinsulin-specific autoantibodies are relatively infrequent in young offspring with pre-type 1 diabetes. Diabetes Care (2001) 0.82

HLA-DQ-restricted, islet-specific T-cell clones of a type I diabetic patient. T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice. Diabetes (1994) 0.82

Alterations of lymphocyte subsets in children of diabetic mothers. Diabetologia (1994) 0.82

Identification of Cys-150 in the active site of phosphomannose isomerase from Candida albicans. Biochemistry (1993) 0.81

Selenomethionine labelling of phosphomannose isomerase changes its kinetic properties. Eur J Biochem (1995) 0.80

Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus. J Neurol Neurosurg Psychiatry (1998) 0.80

Silent coeliac disease is not a cause of autonomic neuropathy in patients with Type 1 diabetes. Diabet Med (2001) 0.80

Two unlinked genes for the pyruvate dehydrogenase complex in Aspergillus nidulans. J Bacteriol (1977) 0.80

Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients. Diabetologia (1996) 0.80

An enzymatic assay for acetate in spent bacterial culture supernatants. Anal Biochem (1983) 0.80

Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes. Exp Clin Endocrinol Diabetes (1996) 0.79

Left ventricular relaxation and filling pattern in diabetic heart muscle disease: an echocardiographic study. Klin Wochenschr (1988) 0.79

Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy. Diabetes Care (1997) 0.79

Petite-negative mutants of Saccharomyces cerevisiae. Mol Gen Genet (1981) 0.79

Influence of bisoprolol on blood glucose, glucosuria, and haemoglobin A1 in noninsulin-dependent diabetics. J Cardiovasc Pharmacol (1986) 0.78

Human monoclonal antibodies isolated from type I diabetes patients define multiple epitopes in the protein tyrosine phosphatase-like IA-2 antigen. J Immunol (2000) 0.78

High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy. Clin Endocrinol (Oxf) (2008) 0.78

Lupus-like panniculitis in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Exp Clin Endocrinol Diabetes (2003) 0.78

Impact of blood pressure on diabetic retinopathy. Diabete Metab (1989) 0.78

Inhibition of phosphomannose isomerase by mercury ions. Biochemistry (1994) 0.77

Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. J Clin Endocrinol Metab (1999) 0.77

Mechanism of irreversible inactivation of phosphomannose isomerases by silver ions and flamazine. Biochemistry (1995) 0.77

Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics. Diabete Metab (1987) 0.77

Insulin autoantibodies with high affinity to the bovine milk protein alpha casein. Clin Exp Immunol (2011) 0.77

Combined antibody screening for improved prediction of IDDM--modern strategies. Exp Clin Endocrinol Diabetes (1997) 0.77

Biochemical estimation of hepatitis B surface antigen in recombinant yeast. Yeast (1987) 0.76

The T-cell receptor beta chain CDR3 region of BV8S1/BJ1S5 transcripts in type 1 diabetes. Immunogenetics (1996) 0.76

Influence of perinatal factors on the appearance of islet autoantibodies in offspring of parents with type 1 diabetes. Pediatr Diabetes (2001) 0.76

Type 1 diabetes mellitus, celiac disease and their association--lessons from antibodies. J Pediatr Endocrinol Metab (2001) 0.76

Evidence for specific autoimmunity against sympathetic and parasympathetic nervous tissues in Type 1 diabetes mellitus and the relation to cardiac autonomic dysfunction. Diabet Med (1998) 0.76

[Type-1 diabetes: the pathogenesis of an immune disease]. Dtsch Med Wochenschr (1994) 0.76

Crystallization and preliminary X-ray analysis of Candida albicans phosphomannose isomerase. J Mol Biol (1994) 0.76

Purification and characterization of 5-ketofructose reductase from Erwinia citreus. Biochem J (1988) 0.75